Cleavage of the death domain kinase RIP by Caspase-8 prompts TNF-induced apoptosis

Genes and Development

Volumn 13, Issue 19, 1999, Pages 2514-2526

  Lin, Yong ^a   Devin, Anne ^a   Rodriguez, Yolanda ^a   Liu, Zheng Gang ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Apoptosis; Caspase; NF B; RIP; TNF

Indexed keywords

ASPARTIC ACID; CASPASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHOTRANSFERASE; TUMOR NECROSIS FACTOR;

APOPTOSIS; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; ENZYME ACTIVE SITE; ENZYME DEGRADATION; ENZYME REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; ASPARTIC ACID; BINDING SITES; CARRIER PROTEINS; CASPASE 8; CASPASE 9; CASPASES; CELL LINE, TRANSFORMED; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; HELA CELLS; HUMANS; MEMBRANE GLYCOPROTEINS; NF-KAPPA B; PROTEIN KINASES; PROTEINS; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; RECEPTORS, TUMOR NECROSIS FACTOR; TNF RECEPTOR-ASSOCIATED FACTOR 1; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033214236     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.13.19.2514     Document Type: Article

References (61)

1. Ashkenazi, A. and V.M. Dixit. 1998. Death receptors: Signaling and modulation. Science 281: 1305-1308.
2. Baeuerle, P.A. 1998. IκB-NF-κB structures: At the interface of inflammation control. Cell 95: 729-731.
3. Baeuerle, P.A. and D. Baltimore. 1996. NF-κB: Ten years after. Cell 87: 13-20.
4. Baker, S.J. and E.P. Reddy. 1998. Modulation of life and death by the TNF receptor superfamily. Oncogene 17: 3261-3270.
5. Beg, A.A. and D. Baltimore. 1996. An essential role for NF-κB in preventing TNFα-induced cell death. Science 274: 782-784.
6. Boldin, M.P., E.E. Varfolomeev, Z. Pancer, I.L. Mett, J.H. Camonis, and D. Wallach. 1995. A novel protein that interacts with the death domain of Ras/APO1 contains a sequence motif related to the death domain. J. Biol. Chem. 270: 7795-7798.
7. Boldin, M.P., T.M. Goncharov, Y.V. Goltsev, and D. Wallach. 1996. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1 and TNF receptor-induced cell death. Cell 85: 803-815.
8. Brenner, D.A., M. O'Hara, P. Angel, M. Chojkier, and M. Karin. 1989. Prolonged activation of jun and collagenase genes by tumor necrosis factor-alpha. Nature 337: 661-663.
9. Chaudhary, P.M., M. Eby, A. Jasmin, A. Bookwalter, J. Murray, and L. Hood. 1997. Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-κB pathway. Immunity 7: 821-830.
10. Chinnaiyan, A.M., K. O'Rourke, M. Tewari, and V.M. Dixit. 1995. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81: 505-512.
11. Cohen, G.M. 1997. Caspases: The executioners of apoptosis. Biochem. J. 326: 1-16.
12. Cryns, V. and J. Yuan. 1998. Proteases to die for. Genes & Dev. 12: 1551-1570.
13. DiDonato, J.A., M. Hayakawa, D.M. Rothwarf, E. Zandi, and M. Karin. 1997. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature 388: 548-554.
14. Duan. H. and V.M. Dixit. 1997. RAIDD is a new 'death' adapter molecule. Nature 385: 86-89.
15. Duckett, C.S. and C.B. Thompson. 1997. CD30-dependent degradation of TRAF2: Implications for negative regulation of TRAF signaling and the control of cell survival. Genes & Dev. 11: 2810-2821.
16. Faleiro, L., R. Kobayashi, H. Feamhead, and Y. Lazebnik. 1997. Multiple species of CPP32 and Mch2 are the major active caspases present in apoptotic cells. EMBO J. 16: 2271-2281.
17. Hsu, H., H.-B. Shu, M-G. Pan, and D.V. Goeddel. 1996a. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84: 299-308.
18. Hsu, H., J. Huang, H.-B. Shu, V. Baichwal, and D.V. Goeddel. 1996b. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 4: 387-396.
19. Hsu, H., J. Xiong, and D.V. Goeddel. 1995. The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell 81: 495-504.
20. Itoh, N. and S. Nagata. 1993. A novel protein domain required for apoptosis: Mutational analysis of human FAS antigen. J. Biol. Chem. 268: 10932-10937.
21. Jiang, Y., J.D. Woronicz, W. Liu, and D. Goeddel. 1999. Prevention of constitutive TNF receptor 1 signaling by silencer of death domains. Science 283: 543-546.
22. Karin, M., Z.G. Liu, and E. Zandi. 1997. AP-1 function and regulation. Curr. Opin. Cell. Biol. 9: 240-246.
23. Kelliher, M.A., S. Grimm, Y. Ishida, F. Kuo, B.Z. Stanger, and P. Leder. 1998. The death domain kinase RIP mediates the TNF-induced NF-κB signal. Immunity 8: 297-303.
24. Lazebnik, Y.A., S.H. Kaufmann, S. Desnoyers, G.G. Poirier, and W.C. Earnshaw. 1994. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371: 346-347.
25. Lee, S.Y., A. Reichlin, A. Santana, K.A., Sokol, M.C. Nussenzweig, and Y. Choi. 1997. TRAF2 is essential for JNK but not NF-κB activation and regulates lymphocyte proliferation and survival. Immunity 7: 703-713.
26. Li, H., H. Zhu, C.-J. Xu, and J. Yuan. 1998. Cleavage of BID by Caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94: 491-501.
27. Luo, X., I. Budihardjo, H. Zou, C. Slaughter, and X. Wang. 1998. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94: 481-490.
28. Liu, Z.G., H. Hsu, D.V. Goeddel, and M. Karin. 1996. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell 87: 565-576.
29. Malinin, N.L., M.P. Boldin, A.V. Kovalenko, and D. Wallach. 1997. MAP3K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1. Nature 385: 540-544.
30. Mercurio, F., H. Zhu, B.W. Murray, A. Shevchenko, B.L. Bennett. J. Li, D.B. Young, M. Barbosa, M. Mann, A. Manning, and A. Rao. 1997. IKK-1 and IKK-2: Cytokine-activated IκB kinases essential for NF-κB activation. Science 278: 860-866.
31. Nagata, S. and P. Golstein. 1995. The Fas death factor. Science 267: 1449-1456.
32. Nagata, S. 1997. Apoptosis by death factor. Cell 88: 355-365.
33. Natoli, G., A. Costanzo, A. Ianni, D.J. Templeton, J.R. Woodgett, C. Balsano, and M. Levrero. 1997. Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway. Science 275: 200-203.
34. Osborn, L., S. Kunkel, and G.J. Nabel. 1989. Tumor necrosis factor and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor κB. Proc. Natl. Acad. Sci. 86: 2336-2340.
35. Pan, G., K.A.M. O'Rourke, R. Chinnaiyan, R. Gentz, R. Ebner, J. Ni, and V.M. Dixit. 1997. The receptor for the cytotoxic ligand TRAIL. Science 276: 111-113.
36. Ray, C.A., R.A. Black, S.R. Kronheim, T.S. Greenstreet, P.R. Sleath, G.S. Salvessen, and D.J. Pickup. 1992. Viral inhibition of inflammation: Cowpox virus encodes an inhibitor of the interleukin-1β converting enzyme. Cell 69: 587-604.
37. Regnier, C.H., H.Y. Song, X. Gao, D.V. Goeddel, Z. Cao, and M. Rothe. 1997. Identification and characterization of an IκB kinase. Cell 90: 373-383.
38. Reinhard, C., B. Shamoon, V. Shyamala, and L.T. Williams. 1997. Tumor necrosis factor alpha-induced activation of c-jun amino-terminal kinase is mediated by TRAF2. EMBO J. 16: 1080-1092.
39. Rothe, M., S.C. Wong, W.J. Henzel, and D.V. Goeddel. 1994. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 κDa tumor necrosis factor receptor. Cell 78: 681-692.
40. Rothe, M., M.-G. Pan, W.J. Henzel, T.M. Ayres, and D.V. Goeddel. 1995. The TNFR2-TRAF signaling complex contains two novel proteins related to baculovirus inhibitor or apoptosis proteins. Cell 83: 1243-1252.
41. Siebenlist, U., G. Franzoso, and K. Brown. 1994. Structure, regulation and function of NF-κB. Annu. Rev. Cell. Biol. 10: 405-455.
42. Smith, C.A., T. Farrah, and R.G. Goodwin. 1994. The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death. Cell 76: 959-962.
43. Srinivasan, A., F. Li, A. Wong, L. Kodandapani, R. Smidt, J.F. Krebs, L.C. Fritz, J.C. Wu, and K.J. Tomaselli. 1998. Bcl-x1 functions downstream of caspase-8 to inhibit Fas-and tumor necrosis factor receptor 1-induced apoptosis of MCF7 breast carcinoma cells. J. Biol. Chem. 273: 4523-4529.
44. Stanger, B.Z., P. Leder, T.H. Lee, E. Kim, and B. Seed, 1995. RIP: A novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell 81: 513-523.
45. Sun, X.M., M. MacFarlane, J. Zhuang, B.B. Wolf, D.R. Green, and G.M. Cohen. 1999. Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis. J. Biol. Chem. 274: 5053-5060.
46. Tartaglia, L.A. and D.V. Goeddel. 1992. Two TNF receptors. Immunol. Today 13: 151-153.
47. Tartaglia, L.A., T.M. Ayres, G.H.W. Wong, and D.V. Goeddel. 1993. A novel domain within the 55 Kd TNF receptor signals cell death. Cell 74: 845-853.
48. Ting, A.T., F.X. Pimentel-Muinos, and B. Seed. 1996. RIP mediates tumor necrosis factor receptor 1 activation of NF-κB but not Fas/APO-1-initiated apoptosis. EMBO J. 15: 6189-6196.
49. Tracey, K.J. and A. Cerami. 1993. Tumor necrosis factor, other cytokines and disease. Annu. Rev. Cell Biol. 9: 317-343.
50. Van Antwerp, D.J., S.J. Martin, T. Kafri, D.R. Green, and I.M. Verma. 1996. Suppression of TNF-alpha-induced apoptosis by NF-κB. Science 274: 787-789.
51. Van Antwerp, D.J., S.J. Martin, I.M. Verma, and D.R. Green. 1998. Inhibition of TNF-induced apoptosis by NF-κB. Trends Cell Biol. 8: 107-111.
52. Varfolomeev, E.E., M. Schuchmann, V. Luria, N. Chiannilkulchai, J.S. Beckmann, I.L. Mett, D. Rebrikov, V.M. Brodianski, O.C. Kemper, O. Kollet, T. Lapidot, D. Soffer, T. Sobe, K.B. Avraham, T. Goncharov, H. Holtmann, P. Lonai, and D. Wallach. 1998. Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/ Apo1, and DR3 and is lethal prenatally. Immunity 9: 267-276.
53. Vandenabeele, P., W. Declercg, R. Beyaert, and W. Fiers. 1995. Two tumour necrosis factor receptors: Structure and function. Trends Cell Biol. 5: 392-399.
54. Walczak, H., M.A. Degli-Esposti, R.S. Johnson, P.J. Smolak, J.Y. Waugh, N. Boiani, M.S. Timour, M.J. Gerhart, K.A. Schooley, C.A. Smith, R.G. Goodwin, and C.T. Rauch. 1997. TRAIL-R2: A novel apoptosis-mediating receptor for TRAIL. EMBO J. 16: 5386-5397.
55. Wang, C.Y., M.W. Mayo, and A.S. Baldwin, Jr. 1996. TNF-and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB. Science 274: 784-787.
56. Wang, C.Y., M.W. Mayo, R.G. Korneluk, D.V. Goeddel, and A.S. Baldwin, Jr. 1998. NF-κB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and C-IAP2 to suppress caspase-8 activation. Science 281: 1680-1683.
57. Wu, M.X., Z. Ao, K.V. Prasad, R. Wu, and S.F. Schlossman. 1998. IEX-1L, an apoptosis inhibitor involved in NF-κB-mediated cell survival. Science 281: 998-1001.
58. Yeh, W.C., A. Shahinian, D. Speiser, J. Kraunus, F. Billia, A. Wakeham, J.L. de la Pompa, D. Ferrick, B. Hum, N. Iscove, P. Ohashi, M. Rothe, D.V. Goeddel, and T.W. Mak. 1997. Early lethality, functional NF-κB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity 7: 715-725.
59. Yeh, W.C., J.L. Pompa, M.E. McCurrach, H.B. Shu, A.J. Elia, A. Shahinian, M. Ng, A. Wakeham, W. Khoo, K. Mitchell, W.S. El-Deiry, S.W. Lowe, D.V. Goeddel, and T.W. Mak. 1998. FADD: Essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science 279: 1954-1958.
60. Zhang, J., D. Cado, A. Chen, N.H. Kabra, and A. Winoto. 1998. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1. Nature 392: 296-300.
61. Zheng, L.X. and M. Lenardo. 1999. NF-κB regulates Fas/APO-1/CD95-and TCR-mediated apoptosis of T lymphocytes. Eur. J. Immunol. 29: 878-886.